Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy
Why the study?
Do implantable cardioverter-defibrillators prevent sudden death in high-risk patients with hypertrophic cardiomyopathy?
Structured PICO
Do implantable cardioverter-defibrillators prevent sudden death in high-risk patients with hypertrophic cardiomyopathy?
P
Population
High-risk patients with hypertrophic cardiomyopathy
I
Intervention
Implantable cardioverter-defibrillators
O
Outcome
Prevention of sudden death and termination of ventricular tachycardia or fibrillationhard clinical
Implantable defibrillators are highly effective in terminating ventricular arrhythmias, supporting their role in the primary and secondary prevention of sudden death in high-risk patients with hypertrophic cardiomyopathy.
Authors
Discussion
No takes yet. Share an insight, caveat, or question.
Implication
Supports ICD consideration in high-risk HCM; leaves open need for randomized trials to confirm sudden death prevention.
Cite This Study
Maron et al. (2000) studied this question.